Literature DB >> 17504381

CXCR4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma.

Y-C Yang1, Z-Y Lee, C-C Wu, T-C Chen, C-L Chang, C-P Chen.   

Abstract

The aim of this study is to investigate the expression of CXCR4 receptor in cervical adenocarcinoma and related mechanisms involved in pelvic lymph node metastasis. Immunohistochemistry was used to evaluate the expression of CXCR4 and the association of pelvic lymph node metastasis in archived tissue from clinical stage IB cervical adenocarcinomas (n = 37) and from benign specimens obtained at hysterectomy for other causes (n = 48). The HeLa cell (cervical adenocarcinoma-derived cell) line that expresses CXCR4 was used to study the interaction between the CXCR4 receptor and stromal cell-derived factor 1alpha (SDF-1alpha). Cell migration assays, cell numbers, flow cytometry, cell proliferation assay, and western blot were used to study the function of CXCR4 and its downstream signal transduction. The positive cases were semiquantitatively divided into three score classes according to their staining. Tumors with strong CXCR4 stainings were more likely to have pelvic lymph node metastasis than those with weak or negative stainings (87.5% vs 34.5%; P = 0.014). Only 25% of the benign specimens had weak or negative staining for CXCR4. Functioning CXCR4 receptor was expressed on HeLa cells. SDF-1alpha provoked significant signal transduction events, including chemotaxis and rescue from apoptosis. These actions were apparently mediated by the activation and phosphorylation of the extracellular signal-regulated kinase 1/2 and AKT pathways. We conclude CXCR4 expression is associated with cervical adenocarcinoma cell migration and proliferation, and primary cervical adenocarcinoma cells expressing CXCR4 are significantly more likely to metastasize to pelvic lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17504381     DOI: 10.1111/j.1525-1438.2007.00841.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  13 in total

1.  Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures.

Authors:  David Zagzag; Mine Esencay; Olga Mendez; Herman Yee; Iva Smirnova; Yuanyuan Huang; Luis Chiriboga; Eugene Lukyanov; Mengling Liu; Elizabeth W Newcomb
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

2.  Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma.

Authors:  Feng Lin; Shui-er Zheng; Zan Shen; Li-na Tang; Ping Chen; Yuan-jue Sun; Hui Zhao; Yang Yao
Journal:  Med Oncol       Date:  2010-03-27       Impact factor: 3.064

3.  Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target.

Authors:  Federica Barbieri; Adriana Bajetto; Tullio Florio
Journal:  J Oncol       Date:  2009-12-14       Impact factor: 4.375

4.  Expression of stromal cell-derived factor 1 and CXCR7 in papillary thyroid carcinoma.

Authors:  Zhen Liu; Da-Xin Sun; Xu-Yong Teng; Wei-Xue Xu; Xiang-Peng Meng; Bao-Sheng Wang
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

5.  Correlation of CXCL12 expression and FoxP3+ cell infiltration with human papillomavirus infection and clinicopathological progression of cervical cancer.

Authors:  Fatimah Jaafar; Elda Righi; Victoria Lindstrom; Christine Linton; Mahrokh Nohadani; Susan Van Noorden; Tyler Lloyd; Joshua Poznansky; Gordon Stamp; Roberto Dina; Dulcie V Coleman; Mark C Poznansky
Journal:  Am J Pathol       Date:  2009-10       Impact factor: 4.307

6.  Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma.

Authors:  Zhiwu Ren; Shoulei Liang; Jilong Yang; Xiuxin Han; Luling Shan; Biying Wang; Tianyang Mu; Yanqin Zhang; Xueli Yang; Shunbin Xiong; Guowen Wang
Journal:  Tumour Biol       Date:  2015-11-06

Review 7.  A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.

Authors:  Changyuan Zhang; Jie Li; Yi Han; Jian Jiang
Journal:  Drug Des Devel Ther       Date:  2015-06-24       Impact factor: 4.162

Review 8.  CXCR4 in breast cancer: oncogenic role and therapeutic targeting.

Authors:  Chao Xu; Hong Zhao; Haitao Chen; Qinghua Yao
Journal:  Drug Des Devel Ther       Date:  2015-08-28       Impact factor: 4.162

Review 9.  The role of chemoattractant receptors in shaping the tumor microenvironment.

Authors:  Jiamin Zhou; Yi Xiang; Teizo Yoshimura; Keqiang Chen; Wanghua Gong; Jian Huang; Ye Zhou; Xiaohong Yao; Xiuwu Bian; Ji Ming Wang
Journal:  Biomed Res Int       Date:  2014-07-10       Impact factor: 3.411

10.  Reassessment of CXCR4 chemokine receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-2.

Authors:  Thomas Fischer; Falko Nagel; Stefan Jacobs; Ralf Stumm; Stefan Schulz
Journal:  PLoS One       Date:  2008-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.